AbstractIn a previous issue of the journal Gould, Mullani and Williams wrote an editorial entitled“PET, PTCA and Economic Priorities.”1 The whole subject of positron emission tomography and its use with rubidium to diagnose coronary artery disease vis‐à‐vis thallium imaging is a controversial issue of current interest. As of this writing, scientists and clinicians have vocalized strong views for each imaging technique as the best clinically suitable method to diagnose hemodynamically significant coronary artery disease. I do not pretend to know who is right, but I can assure the reader of the emotionally charged nature of this controversy. The article by Gould and colleagues generated a response by an economist, Dr. Gleason, which subsequently generated a reply by Gould. I thought this topic was of sufficient interest to the readers of Clinical Cardiology that it should be given special article status because of the important issues raised.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً